Patent details

EP3368064 Title: USE OF DNASE TO IMPROVE SAFETY AND EFFICACY OF ANTI-CANCER CHEMOTHERAPY

Basic Information

Publication number:
EP3368064
PCT Application Number:
RU2015000721
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP159073923
PCT Publication Number:
WO2017074211
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF DNASE TO IMPROVE SAFETY AND EFFICACY OF ANTI-CANCER CHEMOTHERAPY
French Title of Invention:
UTILISATION DE DNASE POUR AMÉLIORER LA SÉCURITÉ ET L'EFFICACITÉ D'UNE CHIMIOTHÉRAPIE ANTICANCÉREUSE
German Title of Invention:
VERWENDUNG VON DNASE ZUR VERBESSERUNG DER SICHERHEIT UND WIRKSAMKEIT EINER KREBSCHEMOTHERAPIE
SPC Number:

Dates

Filing date:
29/10/2015
Grant date:
19/05/2021
EP Publication Date:
05/09/2018
PCT Publication Date:
04/05/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/05/2021
EP B1 Publication Date:
19/05/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/10/2021
Expiration date:
29/10/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/05/2021
 
 

Name:
CLS Therapeutics Limited
Address:
Frances House, Sir William Place St. Peter Port, Guernsey, Channel Islands, GY1 1GX, Guernsey (GG)

Inventor

1

Name:
TETS, Viktor Veniaminovich
Address:
Russian Federation (RU)

2

Name:
TETS, Georgy Viktorovich
Address:
Russian Federation (RU)

3

Name:
GENKIN, Dmitry Dmitrievich
Address:
Russian Federation (RU)

Classification

IPC classification:
A61K 38/46; A61K 45/06; A61P 35/00; A61P 43/00; A61K 31/704; A61K 31/513; A61K 31/675; A61K 31/7068; A61K 31/7048;

Publication

European Patent Bulletin

1

Issue number:
202120
Publication date:
19/05/2021
Description:
Grant (B1)

2

Issue number:
202121
Publication date:
26/05/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages